Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD

INTRODUCTION/OBJECTIVE: ADHD is, for many people, a lifelong disease that requires chronic medication use. Stimulant therapy is often recommended as first-line treatment for ADHD. Adherence to stimulant treatment among patients diagnosed with ADHD is poor. Major regulatory agencies have recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardo, Antonio, King, Thomas R, Rafla, Eman, Kando, Judith C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275141/
https://www.ncbi.nlm.nih.gov/pubmed/34262263
http://dx.doi.org/10.2147/DDDT.S309378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275141/
https://www.ncbi.nlm.nih.gov/pubmed/34262263
http://dx.doi.org/10.2147/DDDT.S309378

Ejemplares similares